Shannon Thyme Klinger
Group General Counsel, Novartis
- 15 January
- DIGITAL HEALTHCARE: THE FUTURE IS NOW Building 5, Floor 3, Green Hall
Shannon Thyme Klinger was appointed Group General Counsel of Novartis on June 1, 2018. She is a member of the Executive Committee of Novartis.
Ms. Klinger most recently served as Chief Ethics, Risk and Compliance Officer of Novartis on the Executive Committee of Novartis. Before that, she was Chief Ethics and Compliance Officer and Global Head of Litigation. She joined Novartis in 2011 as General Counsel, North America, for Sandoz in the United States and later became the Global Head of Legal and General Counsel for Sandoz International GmbH. Prior to Novartis, Ms. Klinger worked in the US as a partner at Mayer Brown LLP from 2010 to 2011, senior vice president and general counsel for Solvay Pharmaceuticals Inc. from 2008 to 2010, and vice president of marketing compliance and associate counsel for Barr Laboratories/Duramed Pharmaceuticals from 2005 to 2007. She was also a partner at Alston & Bird LLP, where she focused on litigation and antitrust, pharmaceutical legal and regulatory matters.
Ms. Klinger holds a juris doctor with honors from the University of North Carolina at Chapel Hill and a bachelor’s degree in psychology from the University of Notre Dame (both in the US). She is a member of the board of directors of the SIX Group.
Shannon Klinger was born in 1971 and she is a US citizen.